Beam
Sydney Gagne is a professional with experience in cell therapy process development at Beam Therapeutics, where contributions as a Senior Research Associate I, Research Associate II, and Research Associate I have been made since May 2022. Prior to this role, Sydney gained experience as a Strategic Growth Investment Engineering Intern at Lonza for a summer in 2021. Sydney holds a Bachelor of Science degree in Chemical Engineering with a Biological Concentration from Worcester Polytechnic Institute, earned between 2018 and 2022.
This person is not in any teams
This person is not in any offices
Beam
10 followers
Beam Therapeutics, launched in 2018, is pioneering the use of CRISPR base editing to develop a broad portfolio of advanced genetic medicines.